6,836 CVS Health Corporation $CVS Shares Sold by Focused Alpha LLC

Focused Alpha LLC lowered its holdings in CVS Health Corporation (NYSE:CVS) by 52.9% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 6,087 shares of the pharmacy operator’s stock after selling 6,836 shares during the quarter. Focused Alpha LLC’s holdings in CVS Health were worth $522,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. BlackRock Inc. purchased a new position in CVS Health in the second quarter valued at about $12,747,462,000. State Street Corp raised its stake in shares of CVS Health by 26.3% during the 2nd quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator’s stock worth $7,751,205,000 after acquiring an additional 15,604,883 shares in the last quarter. Wellington Management Group LLP lifted its position in CVS Health by 49.8% during the second quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock valued at $3,496,725,000 after acquiring an additional 11,233,381 shares during the last quarter. Bank of America Corp DE grew its holdings in CVS Health by 148.0% in the second quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock worth $2,398,868,000 after purchasing an additional 13,836,701 shares during the last quarter. Finally, Pzena Investment Management LLC purchased a new position in CVS Health in the second quarter worth $1,217,558,000. Institutional investors own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on CVS shares. Wall Street Zen lowered CVS Health from a “strong-buy” rating to a “buy” rating in a report on Monday. HSBC restated a “hold” rating and set a $103.00 target price on shares of CVS Health in a research note on Monday, July 6th. Argus upped their target price on CVS Health from $104.00 to $114.00 and gave the company a “buy” rating in a research report on Wednesday, August 19th. Cantor Fitzgerald reiterated a “neutral” rating on shares of CVS Health in a research note on Friday, October 9th. Finally, JPMorgan Chase & Co. raised their price target on CVS Health from $111.00 to $118.00 and gave the stock an “overweight” rating in a report on Wednesday, August 12th. Twenty equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $107.80.

CVS Health Stock Performance

Shares of CVS stock opened at $92.68 on Tuesday. The business has a fifty day moving average of $91.68 and a 200 day moving average of $93.33. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. The firm has a market capitalization of $118.53 billion, a price-to-earnings ratio of 11.78, a price-to-earnings-growth ratio of 0.86 and a beta of 0.60.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%. The business had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. During the same quarter in the previous year, the business earned $1.81 EPS. The company’s quarterly revenue was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, research analysts expect that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd will be given a dividend of $0.6650 per share. The ex-dividend date of this dividend is Thursday, October 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 2.9%. CVS Health’s dividend payout ratio (DPR) is currently 70.37%.

About CVS Health

CVS Health Corporation (NYSE: CVS) is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company’s Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services.